Safety and Tolerability of Inhaled Heparin in Idiopathic Pulmonary Fibrosis
Safety and Tolerability of Inhaled Heparin in Idiopathic Pulmonary Fibrosis
About this item
Full title
Author / Creator
Publisher
New Rochelle, NY: Mary Ann Liebert
Journal title
Language
English
Formats
Publication information
Publisher
New Rochelle, NY: Mary Ann Liebert
Subjects
More information
Scope and Contents
Contents
Abnormalities in alveolar coagulation occur in idiopathic pulmonary fibrosis (IPF). Anticoagulants attenuate bleomycin-induced lung fibrosis in animals. In this study, we first examined the pharmacokinetics of inhaled heparin in healthy subjects. Second, we investigated the safety and tolerability of heparin inhalation in IPF patients.
Coagulati...
Alternative Titles
Full title
Safety and Tolerability of Inhaled Heparin in Idiopathic Pulmonary Fibrosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733330401
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733330401
Other Identifiers
ISSN
1941-2711,1941-2703
E-ISSN
1941-2703
DOI
10.1089/jamp.2009.0780
